natimab.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | NatiMab |
| Description | Company Toggle navigation Home Company Development Team Partners Contacts Company NatiMab Therapeutics is an Italian SME located in the premises of the Bioindustr |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 81.88.52.151 |
| Location | Italy |
Related Websites
| Site | Rank |
More to Explore
natimab.com Valuation
|
US$1,737
Last updated: 2023-05-07 08:38:46
natimab.com has Semrush global rank of 0. natimab.com has an estimated worth of US$ 1,737, based on its estimated Ads revenue. natimab.com receives approximately 200 unique visitors each day. Its web server is located in Italy, with IP address 81.88.52.151. According to SiteAdvisor, natimab.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$1,737 |
| Daily Ads Revenue | US$1 |
| Monthly Ads Revenue | US$48 |
| Yearly Ads Revenue | US$577 |
| Daily Unique Visitors | 13 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| natimab.com. | A | 300 | IP: 81.88.52.151 |
| natimab.com. | NS | 3600 | NS Record: dns2.netsons.net. |
| natimab.com. | NS | 3600 | NS Record: dns1.netsons.net. |
| natimab.com. | NS | 3600 | NS Record: dns3.netsons.net. |
| natimab.com. | NS | 3600 | NS Record: dns4.netsons.net. |
| natimab.com. | MX | 300 | MX Record: 10 mail.webecom.it. |
HtmlToTextCheckTime:2023-05-07 08:38:46
| Toggle navigation Home Company Development Team Partners Contacts Company NatiMab Therapeutics is an Italian SME located in the premises of the Bioindustry Park Canavese scientific and technological park, at Colleretto Giacosa (Torino). Registered on 02/01/2008 in Torino, NatiMab was founded by Gianni Garotta, Maurizio Denaro, Marianne Murphy and Gerritt Hagens. On 10/12/2014, two previously key collaborators, Francesco Novelli and Guido Forni joined the company as shareholders. Goal and Clinical Application The overall goal of NatiMab Therapeutics srl is the identification and development of human antibodies (Abs) for the therapy and diagnosis of infectious diseases and cancer. Initially, NatiMab has concentrated on identifying Tumor Associated Antigens (TAAs) that are recognized by Abs in the serum from patients with Pancreatic Ductal Adenocarcinoma (PDAC) using the method of Serological Proteome Analysis (SERPA) (shown in figure 1). Figure 1. SERPA method to identify TAAs |
HTTP Headers
HTTP/1.1 302 Found Date: Wed, 27 Oct 2021 16:47:48 GMT Server: Apache Location: https://natimab.com/ Content-Type: text/html; charset=iso-8859-1 HTTP/2 200 last-modified: Wed, 17 Feb 2021 14:49:21 GMT etag: "1062924-7a17-5bb895305aef4" accept-ranges: bytes content-length: 31255 vary: Accept-Encoding,User-Agent content-type: text/html; charset=utf-8 date: Wed, 27 Oct 2021 16:47:48 GMT server: Apache |
natimab.com Whois Information
Domain Name: NATIMAB.COM Registry Domain ID: 1661256464_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.PublicDomainRegistry.com Registrar URL: http://www.publicdomainregistry.com Updated Date: 2021-04-15T07:34:33Z Creation Date: 2011-06-12T18:42:10Z Registry Expiry Date: 2022-06-12T18:42:10Z Registrar: PDR Ltd. d/b/a PublicDomainRegistry.com Registrar IANA ID: 303 Registrar Abuse Contact Email: abuse-contact@publicdomainregistry.com Registrar Abuse Contact Phone: +1.2013775952 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: DNS1.NETSONS.NET Name Server: DNS2.NETSONS.NET Name Server: DNS3.NETSONS.NET Name Server: DNS4.NETSONS.NET DNSSEC: unsigned >>> Last update of whois database: 2021-09-15T13:06:16Z <<< |